COVID-19 Vaccine Guidance

Policies and standards related to the COVID-19 vaccines that Infection Prevention and Control professionals may use to support their own documentation and best practices during the COVID-19 Pandemic.

• Interim guidance on continuity of immunization programs during the COVID-19 pandemic
• Guidance for Influenza Vaccine Delivery in the Presence of COVID-19
• Preliminary guidance on key populations for early COVID-19 immunization 
• Canada’s COVID-19 Immunization Plan: Saving Lives and Livelihoods
• Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
• Health Canada authorizes first COVID-19 vaccine
• COVID-19 immunization: Federal, provincial and territorial statement of common principle
• COVID-19 vaccines and treatments portal.
• International Coalition of Medicines Regulatory Authorities statement on continuation of vaccine trials
• COVID-19 mRNA vaccines
• Vaccines and treatments for COVID-19: Progress
• Vaccines and treatments for COVID-19: Vaccine rollout
• Recommendations on the use of COVID-19 vaccine(s)
• Pfizer-BioNTech COVID-19 vaccine: What you should know
• Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
• Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
• Planning guidance for administration of COVID-19 vaccine
• Planning guidance for immunization clinics for COVID-19 vaccines
• Moderna COVID-19 vaccine: What you should know
• Vaccine safety, concerns and possible side effects
• Statement on COVID-19 Vaccination in Pregnancy (SOGC)
• Research priorities for COVID-19 vaccines to support public health decisions
• COVID-19: How vaccines are developed
• Vaccine development and approval in Canada